CME Group (NASDAQ:CME) Shares Gap Down – Time to Sell?

CME Group Inc. (NASDAQ:CME)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $261.60, but opened at $252.18. CME Group shares last traded at $252.2520, with a volume of 574,974 shares changing hands.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

• Neutral Sentiment: CME announced a planned CEO succession: longtime chief Terry Duffy will step down in March 2027 and transition to executive chairman, while President and CFO Lynne Fitzpatrick will become CEO. The move also makes Fitzpatrick CME’s first woman chief executive, which supports continuity but adds some near-term uncertainty around the handoff. Article Title
• Neutral Sentiment: The company also highlighted its long-term leadership change in multiple interviews and reports, which may reassure investors that the transition is orderly rather than sudden. Article Title
• Negative Sentiment: CME said it plans to sue the CFTC over approval of crypto perpetual futures, arguing the regulator is improperly treating these products as swaps rather than futures. The legal fight raises regulatory risk and could create uncertainty around CME’s crypto derivatives strategy. Article Title
• Negative Sentiment: Several headlines repeated the lawsuit plan, suggesting the issue is the main driver of today’s weakness as investors focus on possible friction with regulators and the implications for future product approvals. Article Title

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. Weiss Ratings downgraded CME Group from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Thursday, June 11th. Erste Group Bank cut CME Group from a “buy” rating to a “hold” rating in a report on Friday, June 5th. Piper Sandler set a $320.00 price objective on CME Group in a research note on Wednesday. Deutsche Bank Aktiengesellschaft decreased their price objective on CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a report on Thursday, April 23rd. Finally, UBS Group reiterated an “overweight” rating on shares of CME Group in a research report on Monday. Twelve research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, CME Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $305.18.

CME Group Stock Performance

The firm has a market capitalization of $89.28 billion, a PE ratio of 21.02, a P/E/G ratio of 2.82 and a beta of 0.21. The business has a 50-day simple moving average of $280.74 and a 200-day simple moving average of $287.50. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. The firm had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The company’s quarterly revenue was up 14.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.80 EPS. Equities research analysts expect that CME Group Inc. will post 12.28 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be given a $1.30 dividend. The ex-dividend date is Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a yield of 2.1%. CME Group’s dividend payout ratio (DPR) is currently 44.37%.

Insider Buying and Selling at CME Group

In other CME Group news, insider Hilda Harris Piell sold 5,753 shares of CME Group stock in a transaction on Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the completion of the transaction, the insider directly owned 27,702 shares of the company’s stock, valued at $8,438,860.26. The trade was a 17.20% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the transaction, the chief executive officer owned 55,630 shares in the company, valued at $16,606,111.30. The trade was a 38.62% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.30% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of CME. Whipplewood Advisors LLC raised its holdings in shares of CME Group by 2,075.0% in the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after buying an additional 83 shares during the period. Asset Dedication LLC boosted its holdings in CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 37 shares during the period. FNY Investment Advisers LLC purchased a new position in CME Group during the 4th quarter valued at $27,000. Elkhorn Partners Limited Partnership purchased a new position in CME Group during the 4th quarter valued at $27,000. Finally, Hilton Head Capital Partners LLC bought a new position in CME Group in the 4th quarter valued at $28,000. Institutional investors own 87.75% of the company’s stock.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.